In a report released today, Lance Wilkes from Bernstein maintained a Buy rating on Elevance Health (ELV – Research Report), with a price target of $629.00. The company’s shares closed today at $504.36.
Wilkes covers the Healthcare sector, focusing on stocks such as Cigna, HCA Healthcare, and Centene. According to TipRanks, Wilkes has an average return of 15.2% and a 69.44% success rate on recommended stocks.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Elevance Health with a $571.25 average price target.
See the top stocks recommended by analysts >>
Based on Elevance Health’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $42.65 billion and a net profit of $856 million. In comparison, last year the company earned a revenue of $39.93 billion and had a net profit of $865 million
Based on the recent corporate insider activity of 22 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of ELV in relation to earlier this year. Most recently, in December 2023, Blair Williams Todt, the EVP, CLO & CAO of ELV sold 5,492.00 shares for a total of $2,658,237.84.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Elevance Health (ELV) Company Description:
Indiana-based Anthem, Inc. was formed in 2004 after the merger of WellPoint Health Networks Inc. and Anthem, Inc. The company is one of the leading health insurance names, and provides medical benefits through a range of integrated healthcare plans and related services, along with a wide range of specialty products such as life and disability insurance benefits, dental, vision, behavioral health benefit services, as well as long-term care insurance and flexible spending accounts.
Read More on ELV:
- Elevance Health Projects Strong 2024 Earnings and Star Rating Boost
- Elevance Health Declares Quarterly Dividend for Shareholders
- Elevance Health (NYSE:ELV) Jumps after Exceeding Q4 Estimates
- Elevance Health reports Medical membership totaled ~47M at Dec. 31, 2023
- Elevance Health raises quarterly dividend 10.1% to $1.63 per share
